OMID
Price
$0.02
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
1.76M
36 days until earnings call
ROMJF
Price
$0.44
Change
-$0.02 (-4.35%)
Updated
Sep 5 closing price
Capitalization
28.69M
Interact to see
Advertisement

OMID vs ROMJF

Header iconOMID vs ROMJF Comparison
Open Charts OMID vs ROMJFBanner chart's image
Omid
Price$0.02
Change-$0.00 (-0.00%)
Volume$6.5K
Capitalization1.76M
Rubicon Organics
Price$0.44
Change-$0.02 (-4.35%)
Volume$24.6K
Capitalization28.69M
OMID vs ROMJF Comparison Chart in %
Loading...
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
OMID vs. ROMJF commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OMID is a Hold and ROMJF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (OMID: $0.02 vs. ROMJF: $0.44)
Brand notoriety: OMID and ROMJF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: OMID: 18% vs. ROMJF: 51%
Market capitalization -- OMID: $1.76M vs. ROMJF: $28.69M
OMID [@Pharmaceuticals: Generic] is valued at $1.76M. ROMJF’s [@Pharmaceuticals: Generic] market capitalization is $28.69M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OMID’s FA Score shows that 1 FA rating(s) are green whileROMJF’s FA Score has 0 green FA rating(s).

  • OMID’s FA Score: 1 green, 4 red.
  • ROMJF’s FA Score: 0 green, 5 red.
According to our system of comparison, ROMJF is a better buy in the long-term than OMID.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OMID’s TA Score shows that 3 TA indicator(s) are bullish while ROMJF’s TA Score has 4 bullish TA indicator(s).

  • OMID’s TA Score: 3 bullish, 4 bearish.
  • ROMJF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both OMID and ROMJF are a bad buy in the short-term.

Price Growth

OMID (@Pharmaceuticals: Generic) experienced а 0.00% price change this week, while ROMJF (@Pharmaceuticals: Generic) price change was -9.76% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.30%. For the same industry, the average monthly price growth was +9.43%, and the average quarterly price growth was +86.94%.

Reported Earning Dates

OMID is expected to report earnings on Oct 14, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.30% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROMJF($28.7M) has a higher market cap than OMID($1.76M). ROMJF YTD gains are higher at: 34.016 vs. OMID (-7.443).
OMIDROMJFOMID / ROMJF
Capitalization1.76M28.7M6%
EBITDAN/A3.31M-
Gain YTD-7.44334.016-22%
P/E RatioN/A60.49-
RevenueN/A52.2M-
Total CashN/A7.78M-
Total DebtN/A9.7M-
FUNDAMENTALS RATINGS
OMID vs ROMJF: Fundamental Ratings
OMID
ROMJF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
80
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
96100
SMR RATING
1..100
193
PRICE GROWTH RATING
1..100
7941
P/E GROWTH RATING
1..100
6645
SEASONALITY SCORE
1..100
27n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ROMJF's Valuation (70) in the null industry is in the same range as OMID (80). This means that ROMJF’s stock grew similarly to OMID’s over the last 12 months.

OMID's Profit vs Risk Rating (96) in the null industry is in the same range as ROMJF (100). This means that OMID’s stock grew similarly to ROMJF’s over the last 12 months.

OMID's SMR Rating (1) in the null industry is significantly better than the same rating for ROMJF (93). This means that OMID’s stock grew significantly faster than ROMJF’s over the last 12 months.

ROMJF's Price Growth Rating (41) in the null industry is somewhat better than the same rating for OMID (79). This means that ROMJF’s stock grew somewhat faster than OMID’s over the last 12 months.

ROMJF's P/E Growth Rating (45) in the null industry is in the same range as OMID (66). This means that ROMJF’s stock grew similarly to OMID’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
OMIDROMJF
RSI
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
89%
Bearish Trend 4 days ago
85%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bullish Trend 6 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
68%
Advances
ODDS (%)
Bullish Trend 20 days ago
88%
Bullish Trend 7 days ago
71%
Declines
ODDS (%)
N/A
Bearish Trend 4 days ago
82%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
81%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
OMID
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROMJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HY37.700.58
+1.56%
Hyster-Yale Inc.
GIB96.731.44
+1.51%
CGI
SFNC20.88-0.28
-1.32%
Simmons First National Corp
ANIK8.94-0.15
-1.65%
Anika Therapeutics
IMRN1.86-0.03
-1.69%
Immuron Limited

OMID and

Correlation & Price change

A.I.dvisor tells us that OMID and EOLS have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OMID and EOLS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OMID
1D Price
Change %
OMID100%
N/A
EOLS - OMID
22%
Poorly correlated
+2.00%
OILFF - OMID
8%
Poorly correlated
-10.49%
PHCUF - OMID
5%
Poorly correlated
N/A
ROMJF - OMID
2%
Poorly correlated
-4.79%
OASMY - OMID
2%
Poorly correlated
N/A
More

ROMJF and

Correlation & Price change

A.I.dvisor tells us that ROMJF and PHCUF have been poorly correlated (+13% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ROMJF and PHCUF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROMJF
1D Price
Change %
ROMJF100%
-4.79%
PHCUF - ROMJF
13%
Poorly correlated
N/A
PCLOF - ROMJF
8%
Poorly correlated
+5.13%
SGIOF - ROMJF
8%
Poorly correlated
N/A
SGIOY - ROMJF
8%
Poorly correlated
+2.98%
RSCI - ROMJF
5%
Poorly correlated
N/A
More